Raymond James Financial Inc. Acquires New Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Raymond James Financial Inc. purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 544,506 shares of the medical instruments supplier's stock, valued at approximately $10,335,000. Raymond James Financial Inc. owned 0.27% of DENTSPLY SIRONA as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of the company. Proficio Capital Partners LLC acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $422,000. Charles Schwab Investment Management Inc. increased its holdings in DENTSPLY SIRONA by 1.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock worth $39,880,000 after acquiring an additional 35,360 shares in the last quarter. LGT Group Foundation raised its position in DENTSPLY SIRONA by 9.4% during the fourth quarter. LGT Group Foundation now owns 85,932 shares of the medical instruments supplier's stock worth $1,631,000 after acquiring an additional 7,357 shares during the period. Riverview Trust Co purchased a new position in DENTSPLY SIRONA during the fourth quarter valued at $26,000. Finally, SRS Capital Advisors Inc. grew its position in shares of DENTSPLY SIRONA by 4,699.0% in the fourth quarter. SRS Capital Advisors Inc. now owns 4,607 shares of the medical instruments supplier's stock valued at $87,000 after purchasing an additional 4,511 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

Remove Ads

DENTSPLY SIRONA Trading Down 1.5 %

Shares of XRAY stock traded down $0.23 during trading on Tuesday, hitting $15.57. 2,314,650 shares of the stock traded hands, compared to its average volume of 2,997,019. The firm has a market capitalization of $3.10 billion, a P/E ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 52-week low of $14.78 and a 52-week high of $33.42. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm's fifty day moving average price is $17.86 and its 200-day moving average price is $20.40.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.11%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on XRAY. Evercore ISI reaffirmed an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Thursday, March 13th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Finally, Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $23.33.

Insider Buying and Selling

In related news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.